AI assistant
STERIS plc — Director's Dealing 2022
Dec 5, 2022
30229_dirs_2022-12-05_6b4a124b-830c-4afb-b618-c47d195a0676.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2022-12-01
Reporting Person: Majors Cary L (SVP and President, Healthcare)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-01 | Ordinary Shares | S | 1600 | $192.51 | Disposed | 12495 | Direct |
Footnotes
F1: Price reflects a weighted average sale price for multiple transactions ranging from $192.48 to $192.55 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: As of December 5, 2022, 9,387 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025 and 2,140 on June 2, 2026.